Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 9/22/2025

Asthma Treatment Guidelines

Introduction to Asthma Treatment

  • The American Academy of Family Physicians recommends a stepwise approach for asthma treatment, escalating therapy from as-needed short-acting bronchodilators to high-dose combination therapy with biologics or oral corticosteroids, with treatment adjusted upward to achieve control and stepped down when stable 1, 2

Core Principles of Asthma Treatment

  • The American Academy of Family Physicians suggests that all patients require assessment of adherence, environmental control, comorbidities, and inhaler technique at each step before escalating therapy 1
  • The American Journal of Respiratory and Critical Care Medicine states that treatment intensity should be adjusted based on current asthma control rather than remaining static 3, 4, 5

Universal Elements Across All Steps

  • The American Academy of Family Physicians recommends quick-relief medication with short-acting beta-agonist as needed for all patients at every step 1, 2
  • Patient education, environmental control, and comorbidity management should occur at every level, as recommended by the American Academy of Family Physicians 1

The Six Treatment Steps

  • For intermittent asthma, the American Academy of Family Physicians recommends short-acting beta-agonist as needed only, with no daily controller medication required 1, 2
  • For mild persistent asthma, the American Academy of Family Physicians suggests low-dose inhaled corticosteroid as the preferred treatment, with alternatives including cromolyn, leukotriene receptor antagonist, nedocromil, or theophylline 1, 2, 6
  • For moderate persistent asthma, the American Academy of Family Physicians recommends low-dose inhaled corticosteroid plus long-acting inhaled beta-agonist, or medium-dose inhaled corticosteroid alone, as the preferred treatment 1, 2
  • For severe persistent asthma, the American Academy of Family Physicians suggests high-dose inhaled corticosteroid plus long-acting beta-agonist, with consideration of omalizumab for patients with allergic asthma 1, 2, 6

Stepping Up or Down Treatment

  • The American Academy of Family Physicians recommends stepping up treatment if symptoms are not well-controlled, and stepping down treatment when asthma is well-controlled for at least three months 1, 2
  • Before stepping up treatment, the American Academy of Family Physicians suggests verifying medication adherence, proper inhaler technique, environmental trigger control, and evaluating for comorbidities 1, 7

Critical Pitfalls to Avoid

  • The American Academy of Family Physicians warns against ignoring exacerbation history, relying on symptoms alone, and assessing severity during acute exacerbations 2
  • The American Journal of Respiratory and Critical Care Medicine notes that well-controlled asthma can only be achieved in approximately 70% of patients across severity strata, even with optimal therapy 3, 4, 5

Important Medication Considerations

  • The American Academy of Family Physicians states that inhaled corticosteroids are the most effective single long-term controller medication for improving asthma control across all severity levels 2
  • The American Academy of Family Physicians recommends annual influenza vaccination for all patients with persistent asthma 7

REFERENCES

2

Asthma Classification and Management [LINK]

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

3

optimal asthma control: time for a new target. [LINK]

American Journal of Respiratory and Critical Care Medicine, 2020

4

optimal asthma control: time for a new target. [LINK]

American Journal of Respiratory and Critical Care Medicine, 2020

5

optimal asthma control: time for a new target. [LINK]

American Journal of Respiratory and Critical Care Medicine, 2020

6

attaining optimal asthma control: a practice parameter. [LINK]

Journal of Allergy and Clinical Immunology, 2005